Drugs / Sf2aWC
Sf2aWC
English name Shigella flexneri 2a whole cell killed vaccine
also known as
Shigella flexneri 2a whole cell killed vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01509846 | Mar 2011 → Dec 2012 | shigellosis | PATH | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sf2aWC | “Shigella flexneri 2a whole cell killed vaccine (Sf2aWC)” NCT01509846 ↗ |
| Known as | Shigella flexneri 2a whole cell killed vaccine | “The rationale for using Shigella flexneri 2a whole cell killed vaccine (Sf2aWC), is that it is expected to be especially well tolerated by subjects.” NCT01509846 ↗ |
| Modality | Vaccine | “Sf2aWC is a killed vaccine” NCT01509846 ↗ |
| Route | Oral | “single oral dose of Sf2aWC” NCT01509846 ↗ |